Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET.

scientific article published in December 2017

Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/MD.0000000000009042
P932PMC publication ID5728822
P698PubMed publication ID29310421

P50authorYoung Jin JeongQ56974268
P2093author name stringHyun Jin Yoon
Young Jin Jeong
Do-Young Kang
P2860cites workAlzheimer's DiseaseQ22248111
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseaseQ24203739
Mechanisms of Aβ Clearance and Degradation by Glial CellsQ26741609
Neuropathological alterations in Alzheimer diseaseQ27003314
Neuroinflammation in Alzheimer's diseaseQ28259238
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseQ29547554
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memoryQ29614724
Microglia: a sensor for pathological events in the CNSQ29620556
Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions.Q30873038
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.Q33697980
Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imagingQ33904501
Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysisQ34042034
Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severityQ34100175
Molecular imaging of microglia/macrophages in the brainQ34276818
Neuroinflammation in Alzheimer's disease and prion disease.Q34963776
Local neuroinflammation and the progression of Alzheimer's diseaseQ35022588
Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET StudyQ35935113
Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementiaQ36775208
Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.Q37720604
Inflammation in neurodegenerative diseasesQ37766302
Is Alzheimer's a disease of the white matter?Q38089525
Glucose pathways adaptation supports acquisition of activated microglia phenotypeQ38186639
Brain PET in suspected dementia: patterns of altered FDG metabolismQ38211221
Oligodendrocytes and Alzheimer's diseaseQ38497880
Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?Q38677275
Neuroinflammation in Alzheimer's disease: Current evidence and future directionsQ38834651
Typical cerebral metabolic patterns in neurodegenerative brain diseasesQ42952840
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET studyQ46373170
An early and late peak in microglial activation in Alzheimer's disease trajectoryQ48339994
Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.Q48529217
Mapping biochemistry to metabolism: FDG-PET and amyloid burden in Alzheimer's disease.Q52138509
In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease.Q53416070
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndromeQ70908071
White matter amyloid in Alzheimer's disease brainQ71773128
P433issue48
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
Fluorodeoxyglucose Positron Emission TomographyQ130273243
P304page(s)e9042
P577publication date2017-12-01
P1433published inMedicineQ15716652
P1476titleAssessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET.
P478volume96

Reverse relations

cites work (P2860)
Q89460111Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease
Q89820448Utility of Absolute Quantification in Non-lesional Extratemporal Lobe Epilepsy Using FDG PET/MR Imaging
Q57290382Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease

Search more.